Skip to main content
petri dish

Hold’em for Life Early Career Professorships in Cancer Research

AWARD OVERVIEW

 

NOI Deadline: Monday, April 6, 2026
 

Application Deadline: Friday, May 8, 2026
 

Value: $225,000 over a three-year (3-year) term
 

Eligibility: Early-Career Clinician Scientists (see details below)
 

Results Available: June 2026

Acknowledging that starting a career as a clinician scientist has become increasingly challenging given limited opportunities, the Hold’em for Life Early Career Professorship in Cancer Research is designed to help launch the careers of early‑stage researchers and provide them with essential initial support.

The Office of the Vice Dean, Research and Health Science Education, together with the Office of Academic HR, at the Temerty Faculty of Medicine, is committed to supporting early‑career clinician scientists as a top priority. We are pleased to announce additional funding for at least one Hold’em for Life Early Career Professorship in Cancer Research, which provides resources to advance the research activity and career development of new clinician scientists, clinician investigators, and quality & innovation clinicians (within the first five years of their academic appointment), with the goal of enhancing innovation in academic medicine.

This professorship is valued at $225,000 ($75,000 per year for three years) and will be awarded to a clinical faculty member focused on any aspect of cancer research who holds a full‑time academic appointment in the Temerty Faculty of Medicine.

This early career professorship is made possible through the generous support of Hold’em for Life. Founded in 2006, Hold’em for Life is an entirely volunteer‑run nonprofit organization dedicated to raising funds for cancer research. In 2019, the organization made a transformative gift to support cancer research and education, establishing the Hold’em for Life Oncology Fellowships at the University of Toronto’s Temerty Faculty of Medicine and its partner hospitals. Since then, 138 fellowships have been awarded to clinician‑scientist trainees. Hold’em for Life continues to invest in the clinician‑scientist talent pipeline by supporting faculty early in their independent careers. To date, 18 clinical faculty members have been awarded the Hold’em for Life Early Career Professorship in Cancer Research.

The Temerty Faculty of Medicine is strongly committed to diversity within its community and especially welcomes awards applications from racialized persons/persons of colour, women, Indigenous/Aboriginal People of North America, persons with disabilities, LGBTQ2S+ persons, and others who may contribute to the further diversification of ideas.

Purpose

To support the career trajectory and research activities of early‑career clinician scientists by protecting dedicated research time and providing resources that enable their success in academic medicine, specifically in the area of cancer research.

Value and Duration

The professorship is valued at $225,000 over a three-year (3-year) term ($75,000 per annum) effective July 1, 2026. At least one professorship will be available for the July 1, 2026 start date.

Eligibility Criteria

Early-Career Clinician Scientists, Clinical Investigators, and Quality & Innovation (QI) clinicians working in all areas of cancer research, including basic science, preclinical and clinical research, and knowledge translation are eligible to apply.

Full time clinical faculty members with an academic position description of Clinician Scientist, Clinical Investigators and QIs, at the minimum rank of Assistant Professor within the first 5 years of their academic appointment are eligible to apply. Applicants with confirmed offers for full-time academic appointment in Temerty Faculty of Medicine are also eligible to apply. 

Applicants who are more than five (5) years beyond their first academic appointment but have experienced career interruptions such as maternity or parental leave, extended sick leave, or clinical training, may have their eligibility considered by the review committee.  At the Notice of Intent stage, applicants should include a brief statement and timeline outlining any disruptions.

Deadlines and Important Dates

  1. Notice of Intent deadline: Monday, April 6, 2026
  2. Full application deadline: Friday, May 8, 2026
  3. Decisions made:  June 2026
  4. Funding start date: July 1, 2026

Full Application Details

Completed applications should be emailed to patricia.cayetano@utoronto.ca by 5pm on Friday, May 8, 2026.

  1. Application cover sheet
  2.  Research Summary
    • Include a one‑page research statement describing how your program supports or plans to advance cancer research. Please include:
      • Title of the proposal
      • Broad goals of the proposed research
      • Relevant background and/or rationale for the proposed work
      • Specific research aims, including a brief overview of the methodology used to address each aim
      • Description of core expertise and collaborations (within or outside the research community) that will contribute to achieving the research goals
      • Expected outcomes and the potential significance or impact of the research
        • Describe how the work will advance knowledge and/or contribute to improved health care, health systems, or health outcomes in the context of cancer
  3. Detailed Research Proposal (3-4 pages, inclusive of references)
    • Provide a detailed narrative of your research plan. Highlight the originality of the research concept, your approach, and how your expertise positions you for success. Describe how the findings will contribute to disease understanding, identify potential therapies, and support trainee supervision and mentorship.
    • Include the following sections:
      • Introduction
      • Proposed Research Program
      • Significance and Innovation
      • Translation Strategy
  4. List of top 5 publications or scholarly outputs (1 page)
    • List your top five publications or comparable scholarly outputs in order of significance or impact.
    • All outputs must be completed and published. Works in progress or under review will not be considered.
    • You may include a brief description highlighting the importance of each selected publication.
  5. Well-formatted CV 
    • Submit an up‑to‑date CV, tailored to your clinical research achievements (maximum 30 pages).

Review Process

A committee chaired by the Director of Clinical Research and Translation will review all submitted applications. Reviewers will be required to declare any potential conflicts of interest prior to being assigned applications. Following the review process, the top candidates will be recommended to the Dean of the Temerty Faculty of Medicine for appointment to the professorship.

Administration and Reporting

Funds may be provided to awardees as a stipend, a research allowance to support their research program, or a combination of the two.

The successful applicant must submit an annual report to the Director of Clinical Research and Translation prior to the award’s anniversary date each year.

Questions regarding the Hold’em for Life Early Career Professorship in Cancer Research, please contact Patricia Cayetano, Academic HR Officer at patricia.cayetano@utoronto.ca